Ryan J Carlson1, Alicia Quesnel2,3, Dawson Wells2,3, Zippora Brownstein4, Dror Gilony4,5, Suleyman Gulsuner1, Kathleen A Leppig6, Karen B Avraham4, Mary-Claire King1, Tom Walsh1, Jay Rubinstein7. 1. Departments of Genome Sciences and Medicine, University of Washington, Seattle, Washington. 2. Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts. 3. Otopathology Laboratory, Massachusetts Eye and Ear, Boston, Massachusetts. 4. Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel. 5. Pediatric Otolaryngology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel. 6. Genetic Services, Kaiser Permanente of Washington, Seattle, Washington. 7. Virginia Merrill Bloedel Hearing Research Center, Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington.
Abstract
OBJECTIVES: To better distinguish NOG-related-symphalangism spectrum disorder (NOG-SSD) from chromosomal 17q22 microdeletion syndromes and to inform surgical considerations in stapes surgery for patients with NOG-SSD. BACKGROUND: Mutations in NOG cause a variety of skeletal syndromes that often include conductive hearing loss. Several microdeletions of chromosome 17q22 lead to severe syndromes with clinical characteristics that overlap NOG-SSD. Isolated deletion of NOG has not been described, and therefore the contribution of NOG deletion in these syndromes is unknown. METHODS: Two families with autosomal dominant NOG-SSD exhibited stapes ankylosis, facial dysmorphisms, and skeletal and joint anomalies. In each family, NOG was evaluated by genomic sequencing and candidate mutations confirmed as damaging by in vitro assays. Temporal bone histology of a patient with NOG-SSD was compared with temporal bones of 40 patients diagnosed with otosclerosis. RESULTS: Family 1 harbors a 555 kb chromosomal deletion encompassing only NOG and ANKFN1. Family 2 harbors a missense mutation in NOG leading to absence of noggin protein. The incus-footplate distance of the temporal bone was significantly longer in a patient with NOG-SSD than in patients with otosclerosis. CONCLUSION: The chromosomal microdeletion of family 1 led to a phenotype comparable to that due to a NOG point mutation and much milder than the phenotypes due to other chromosome 17q22 microdeletions. Severe clinical findings in other microdeletion cases are likely due to deletion of genes other than NOG. Based on temporal bone findings, we recommend that surgeons obtain longer stapes prostheses before stapes surgery in individuals with NOG-SSD stapes ankylosis.
OBJECTIVES: To better distinguish NOG-related-symphalangism spectrum disorder (NOG-SSD) from chromosomal 17q22 microdeletion syndromes and to inform surgical considerations in stapes surgery for patients with NOG-SSD. BACKGROUND: Mutations in NOG cause a variety of skeletal syndromes that often include conductive hearing loss. Several microdeletions of chromosome 17q22 lead to severe syndromes with clinical characteristics that overlap NOG-SSD. Isolated deletion of NOG has not been described, and therefore the contribution of NOG deletion in these syndromes is unknown. METHODS: Two families with autosomal dominant NOG-SSD exhibited stapes ankylosis, facial dysmorphisms, and skeletal and joint anomalies. In each family, NOG was evaluated by genomic sequencing and candidate mutations confirmed as damaging by in vitro assays. Temporal bone histology of a patient with NOG-SSD was compared with temporal bones of 40 patients diagnosed with otosclerosis. RESULTS: Family 1 harbors a 555 kb chromosomal deletion encompassing only NOG and ANKFN1. Family 2 harbors a missense mutation in NOG leading to absence of noggin protein. The incus-footplate distance of the temporal bone was significantly longer in a patient with NOG-SSD than in patients with otosclerosis. CONCLUSION: The chromosomal microdeletion of family 1 led to a phenotype comparable to that due to a NOG point mutation and much milder than the phenotypes due to other chromosome 17q22 microdeletions. Severe clinical findings in other microdeletion cases are likely due to deletion of genes other than NOG. Based on temporal bone findings, we recommend that surgeons obtain longer stapes prostheses before stapes surgery in individuals with NOG-SSD stapes ankylosis.
Authors: K Van Den Bogaert; E M R De Leenheer; W Chen; Y Lee; P Nürnberg; R J E Pennings; K Vanderstraeten; M Thys; C W R J Cremers; R J H Smith; G Van Camp Journal: J Med Genet Date: 2004-06 Impact factor: 6.318
Authors: Vassiliki Iliadou; Kris Van Den Bogaert; Nikolaos Eleftheriades; George Aperis; Kathleen Vanderstraeten; Erik Fransen; Melissa Thys; Maria Grigoriadou; Andreas Pampanos; John Economides; Theophilos Iliades; Guy Van Camp; Michael B Petersen Journal: Int J Pediatr Otorhinolaryngol Date: 2005-09-15 Impact factor: 1.675
Authors: K Van Den Bogaert; P J Govaerts; I Schatteman; M R Brown; G Caethoven; F E Offeciers; T Somers; F Declau; P Coucke; P Van de Heyning; R J Smith; G Van Camp Journal: Am J Hum Genet Date: 2001-01-16 Impact factor: 11.025
Authors: Helen Puusepp; Olga Zilina; Rita Teek; Katrin Männik; Sven Parkel; Katrin Kruustük; Kati Kuuse; Ants Kurg; Katrin Ounap Journal: Eur J Med Genet Date: 2008-10-17 Impact factor: 2.708
Authors: Amal Abu Rayyan; Lara Kamal; Silvia Casadei; Zippora Brownstein; Fouad Zahdeh; Hashem Shahin; Christina Canavati; Dima Dweik; Tamara Jaraysa; Grace Rabie; Ryan J Carlson; Suleyman Gulsuner; Ming K Lee; Karen B Avraham; Tom Walsh; Mary-Claire King; Moien N Kanaan Journal: Proc Natl Acad Sci U S A Date: 2020-08-03 Impact factor: 11.205
Authors: Tobias Laurell; Johanna Lundin; Britt-Marie Anderlid; Jerome L Gorski; Giedre Grigelioniene; Samantha J L Knight; Ana C V Krepischi; Agneta Nordenskjöld; Susan M Price; Carla Rosenberg; Peter D Turnpenny; Angela M Vianna-Morgante; Ann Nordgren Journal: Eur J Hum Genet Date: 2013-01-30 Impact factor: 4.246